[Paper Review] New Approach for Prediction Pre-cancer via Detecting Mutated in Tumor Protein P53

Ayad Ghany Ismaeel|arXiv (Cornell University)|Oct 8, 2013

Genetics, Bioinformatics, and Biomedical Research6 references3 citations

TL;DR

This paper proposes a novel bioinformatics approach to predict pre-cancer by detecting pathogenic mutations in the tumor suppressor protein p53 using tools like BLAST, FASTA, ClustalW, and TP53 databases. The method improves diagnostic specificity by applying multiple filtering parameters, enabling early intervention through lifestyle changes or targeted therapies, thus reducing future cancer risk.

ABSTRACT

Tumor protein P53 is believed to be involved in over half of human cancers cases, the prediction of malignancies plays essential roles not only in advance detection for cancer, but also in discovering effective prevention and treatment of cancer, till now there isn't approach be able in prediction the mutated in tumor protein P53 which is caused high ratio of human cancers like breast, Blood, skin, liver, lung, bladder etc. This research proposed a new approach for prediction pre-cancer via detection malignant mutations in tumor protein P53 using bioinformatics tools like FASTA, BLAST, CLUSTALW and TP53 databases worldwide. Implement and apply this new approach of prediction pre-cancer through mutations at tumor protein P53 shows an effective result when used more specific parameters/features to extract the prediction result that means when the user increase the number of filters of the results which obtained from the database gives more specific diagnosis and classify, addition that the detecting pre-cancer via prediction mutated tumor protein P53 will reduces a person's cancers in the future by avoiding exposure to toxins, radiation or monitoring themselves at older ages by change their food, environment, even the pace of living. Also that new approach of prediction pre-cancer will help if there is any treatment can give for that person to therapy the mutated tumor protein P53. Index Terms (Normal Homology TP53 gene, Tumor Protein P53, Oncogene Labs, GC and AT content, FASTA, BLAST, ClustalW)

Motivation & Objective

• To develop a new method for predicting pre-cancer by detecting mutations in the tumor protein p53, a key driver in over half of human cancers.
• To address the lack of existing tools capable of reliably predicting p53 mutations associated with high cancer risk.
• To improve diagnostic specificity by integrating multiple bioinformatics filters and parameters from genomic databases.
• To enable early detection and preventive strategies by identifying individuals at risk before cancer onset.

Proposed method

• The approach uses the FASTA tool to retrieve and analyze p53 protein sequences from genomic databases.
• BLAST is applied to compare query p53 sequences against known reference sequences to identify mutations.
• ClustalW performs multiple sequence alignment to assess evolutionary conservation and mutation impact across species.
• The TP53 database is leveraged to cross-reference identified mutations with known pathogenic variants and functional annotations.
• Multiple filtering parameters—such as GC/AT content, mutation location, and conservation scores—are applied to refine prediction accuracy.
• The final output classifies mutations as likely pathogenic or benign based on integrated bioinformatics criteria.

Experimental results

Research questions

• RQ1 Can a multi-tool bioinformatics pipeline improve the prediction of pathogenic p53 mutations linked to pre-cancer?
• RQ2 How does increasing the number of filtering parameters affect the specificity and reliability of p53 mutation classification?
• RQ3 To what extent can existing databases like TP53 and tools like BLAST and ClustalW be combined to detect early-stage cancer risk?
• RQ4 Can this approach enable earlier clinical intervention through lifestyle or therapeutic strategies?
• RQ5 Does integrating sequence conservation, mutation type, and genomic context enhance prediction accuracy beyond single-parameter methods?

Key findings

• The integration of multiple bioinformatics tools significantly improved the specificity of p53 mutation classification compared to single-method approaches.
• Applying additional filtering parameters—such as GC/AT content and evolutionary conservation—reduced false positives and enhanced diagnostic precision.
• The method successfully identified known pathogenic p53 mutations in databases, validating its predictive accuracy.
• The approach enables early detection of pre-cancerous states by identifying high-risk p53 mutations before clinical onset.
• The system supports potential preventive interventions, including lifestyle modifications and targeted therapies, by identifying individuals at elevated cancer risk.